Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 2, 2010, Pages 193.e1-193.e13

  Semenov, Oleg V ^a,b   Koestenbauer, Sonja ^d   Riegel, Mariluce ^c   Zech, Nikolas ^a   Zimmermann, Roland ^a   Zisch, Andreas H ^a,c   Malek, Antoine ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

human placenta; mesenchymal stem cells; tissue regeneration

Indexed keywords

COLLAGENASE; TRYPSIN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KARYOTYPE; MALE; MESENCHYMAL STEM CELL; MESODERM; MULTIPOTENT STEM CELL; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; TROPHOBLAST;

EID: 74749093962     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.10.869     Document Type: Article

References (41)

1. Brooke G., Cook M., Blair C., et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18 (2007) 846-858
2. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12 (2006) 459-465
3. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8 (2008) 726-736
4. Chamberlain G., Fox J., Ashton B., and Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007) 2739-2749
5. Portmann-Lanz C.B., Schoeberlein A., Huber A., et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 194 (2006) 664-673
6. Ilancheran S., Moodley Y., and Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair?. Placenta 30 (2009) 2-10
7. Jo C.H., Kim O.S., Park E.Y., et al. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res 334 (2008) 423-433
8. Bieback K., Kern S., Kluter H., and Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22 (2004) 625-634
9. Parolini O., Alviano F., Bagnara G.P., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26 (2008) 300-311
10. Marcus A.J., and Woodbury D. Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med 12 (2008) 730-742
11. Battula V.L., Bareiss P.M., Treml S., et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75 (2007) 279-291
12. Battula V.L., Treml S., Abele H., and Buhring H.J. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76 (2008) 326-336
13. Chang C.M., Kao C.L., Chang Y.L., et al. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem Biophys Res Commun 357 (2007) 414-420
14. Chien C.C., Yen B.L., Lee F.K., et al. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 24 (2006) 1759-1768
15. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., and Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22 (2004) 649-658
16. Genbacev O., Krtolica A., Zdravkovic T., et al. Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83 (2005) 1517-1529
17. Igura K., Zhang X., Takahashi K., Mitsuru A., Yamaguchi S., and Takashi T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6 (2004) 543-553
18. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (2004) 1338-1345
19. Miao Z., Jin J., Chen L., et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30 (2006) 681-687
20. Poloni A., Rosini V., Mondini E., et al. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy 10 (2008) 690-697
21. Strakova Z., Livak M., Krezalek M., and Ihnatovych I. Multipotent properties of myofibroblast cells derived from human placenta. Cell Tissue Res 332 (2008) 479-488
22. Yen B.L., Huang H.I., Chien C.C., et al. Isolation of multipotent cells from human term placenta. Stem Cells 23 (2005) 3-9
23. Zhang X., Mitsuru A., Igura K., et al. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 340 (2006) 944-952
24. Zhang X., Soda Y., Takahashi K., et al. Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochem Biophys Res Commun 351 (2006) 853-859
25. Barlow S., Brooke G., Chatterjee K., et al. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17 (2008) 1095-1107
26. Brooke G., Rossetti T., Pelekanos R., et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol 144 (2009) 571-579
27. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
28. Oswald J., Boxberger S., Jorgensen B., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22 (2004) 377-384
29. Ehrbar M., Metters A., Zammaretti P., Hubbell J.A., and Zisch A.H. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 101 (2005) 93-109
30. Blaschitz A., Weiss U., Dohr G., and Desoye G. Antibody reaction patterns in first trimester placenta: implications for trophoblast isolation and purity screening. Placenta 21 (2000) 733-741
31. Manoussaka M.S., Jackson D.J., Lock R.J., Sooranna S.R., and Kumpel B.M. Flow cytometric characterisation of cells of differing densities isolated from human term placentae and enrichment of villous trophoblast cells. Placenta 26 (2005) 308-318
32. Loges S., Fehse B., Brockmann M.A., et al. Identification of the adult human hemangioblast. Stem Cells Dev 13 (2004) 229-242
33. Tondreau T., Meuleman N., Delforge A., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23 (2005) 1105-1112
34. Miki T., Lehmann T., Cai H., Stolz D.B., and Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23 (2005) 1549-1559
35. Pelosi E., Valtieri M., Coppola S., et al. Identification of the hemangioblast in postnatal life. Blood 100 (2002) 3203-3208
36. Huppertz B. The anatomy of the normal placenta. J Clin Pathol 61 (2008) 1296-1302
37. Kaufmann P. Basic morphology of the fetal and maternal circuits in the human placenta. Contrib Gynecol Obstet 13 (1985) 5-17
38. Mayhew T.M. Thinning of the intervascular tissue layers of the human placenta is an adaptive response to passive diffusion in vivo and may help to predict the origins of fetal hypoxia. Eur J Obstet Gynecol Reprod Biol 81 (1998) 101-109
39. Florek M., Haase M., Marzesco A.M., et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319 (2005) 15-26
40. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
41. Noel D., Djouad F., Bouffi C., Mrugala D., and Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 48 (2007) 1283-1289